Kala Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. EYPT
3. TSLA
4. NVDA
5. AWK
6. GNK
7. USO
8. ARGX
9. SPCX
10. AZN

Go back to Kala Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update

Kala Pharmaceuticals (KALA) Reports In-Line Q2 EPS

August 6, 2020 8:55 AM EDT

Kala Pharmaceuticals (NASDAQ: KALA) reported Q2 EPS of ($0.41), in-line with the analyst estimate of ($0.41).

We are very pleased with our progress in the second quarter, said Mark Iwicki, Chairman, President and Chief Executive Officer of Kala Pharmaceuticals. In May, the FDA accepted our NDA... More